Patent application number | Description | Published |
20100041645 | RHO KINASE INHIBITORS - Substituted amide and urea derivatives useful as inhibitors of Rho kinase are described, which inhibitors can be useful in the treatment of various disorders such as cardiovascular diseases, cancer, neurological diseases, renal diseases, bronchial asthma, erectile dysfunction and glaucoma. | 02-18-2010 |
20100190773 | Anti-Cytokine Heterocyclic Compounds - Heterocyclic compounds and analogues thereof and their use as inhibitors of Mitogen-Activated Protein Kinase-Activated Protein kinase-2 (MAPKAP-k2), and also to a method for preventing or treating a disease or disorder that can be treated or prevented by modulating the activity of MAPKAP-K2 in a subject and to pharmaceutical compositions and kits that include these MAPKAP-K2 inhibitors. | 07-29-2010 |
20110039851 | CCR10 ANTAGONISTS - The invention relates to a compound of formula (I): | 02-17-2011 |
20110053955 | ANTI-CYTOKINE HETEROCYCLIC COMPOUNDS - Heterocyclic compounds which are inhibitors of Mitrogen-Activated Protein Kinase-Activated Protein Kinase-2 (MAPKAP-K2) as described, in addition to their use in the treatment of cytokine mediated diseases. | 03-03-2011 |
20110275612 | ALPHA-SUBSTITUTED N-SULFONYL GYLCINE AMIDES ANTAGONISTS OF CCR10, COMPOSITIONS CONTAINING THE SAME AND METHODS FOR USING THEM - Disclosed is a compound of formula (I). Wherein R | 11-10-2011 |
20110275800 | 2-SULFONYLAMINO-4-HETEROARYL BUTYRAMIDE ANTAGONISTS OF CCR10 - This invention relates to a compound of formula (I) and the pharmaceutically acceptable salts thereof wherein R | 11-10-2011 |
20120270868 | RHO KINASE INHIBITORS - The present invention relates to compounds of formula (I): | 10-25-2012 |
20130109679 | HETEROCYCLIC COMPOUNDS CONTAINING AN INDOLE CORE | 05-02-2013 |
20130137680 | HETEROCYCLIC COMPOUNDS CONTAINING A PYRROLOPYRIDINE OR BENZIMIDAZOLE CORE - The present invention relates to compounds of Formula (I) and pharmaceutically acceptable salt thereof, wherein R | 05-30-2013 |
20140031339 | INHIBITORS OF LEUKOTRIENE PRODUCTION - The present invention relates to compounds of formula (I): | 01-30-2014 |
20140357652 | RHO KINASE INHIBITORS - Disclosed are novel substituted 2H-isoquinolin-1-one and 3H-quinazolin-4-one derivatives useful as inhibitors of Rho kinase and for treating a variety of diseases and disorders that are mediated or sustained through the activity of Rho kinase, including cardiovascular diseases, pharmaceutical compositions comprising such compounds, methods for using such compounds and processes for making such compounds. | 12-04-2014 |